Table 1.

Causes for recurrent VTE for patients who are receiving appropriate anticoagulation therapy

Underlying diseaseMechanismsReference
Cancer Activation of coagulation factors and platelets, inflammatory cytokines with endothelial cell activation, neutrophil extracellular traps, adhesion molecules 10  
Antiphospholipid syndrome Annexin V shield disruption, neutrophil extracellular traps, endothelial cell activation, inhibition of protein C or fibrinolysis 65  
Vasculitis (Behçet disease) Diminished nitric oxide, impaired protein C pathway, elevated platelet-derived microparticles 66  
Paroxysmal nocturnal hemoglobinuria Complement activation, ADP release from lysed red cells, decreased fibrinolysis 67  
Heparin-induced thrombocytopenia Platelet activation, platelet-derived microparticles 68  
Pregnancy Increased coagulation factors, impaired protein C pathway, inhibition of fibrinolysis, compression of left iliac vein 69  
Vascular abnormalities Venous compression in May-Thurner and thoracic outlet syndromes 25  
Underlying diseaseMechanismsReference
Cancer Activation of coagulation factors and platelets, inflammatory cytokines with endothelial cell activation, neutrophil extracellular traps, adhesion molecules 10  
Antiphospholipid syndrome Annexin V shield disruption, neutrophil extracellular traps, endothelial cell activation, inhibition of protein C or fibrinolysis 65  
Vasculitis (Behçet disease) Diminished nitric oxide, impaired protein C pathway, elevated platelet-derived microparticles 66  
Paroxysmal nocturnal hemoglobinuria Complement activation, ADP release from lysed red cells, decreased fibrinolysis 67  
Heparin-induced thrombocytopenia Platelet activation, platelet-derived microparticles 68  
Pregnancy Increased coagulation factors, impaired protein C pathway, inhibition of fibrinolysis, compression of left iliac vein 69  
Vascular abnormalities Venous compression in May-Thurner and thoracic outlet syndromes 25  
Close Modal

or Create an Account

Close Modal
Close Modal